N6-Methyladenosine 5'-monophosphate disodium salt

Catalog No. :
ACGFNG939
CAS No. :
81921-35-9
Molecular Formula :
C11H14N5Na2O7P
Molecular Weight :
405.21

IUPAC Name:sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate

N6-Methyladenosine 5'-monophosphate disodium salt structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg95%$318.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN6-Methyladenosine 5'-monophosphate disodium salt
IUPAC Namesodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate
MDL No.MFCD28098191
Molecular FormulaC11H14N5Na2O7P
Molecular Weight405.21
SMILESCNC1=NC=NC2=C1N=CN2[C@@H]3O[C@@H]([C@H]([C@H]3O)O)COP([O-])([O-])=O.[Na+].[Na+]
InChI KeyHFOKUKRAZPHTHH-LYYWGVPGSA-L
SynonymN6-methyladenosine 5'-monophosphate*sodium;N6-METHYLADENOSINE 5'-MONOPHOSPHATE SODIUM SALT;N6-Methyladenosine 5'-Monophosphate sodiuM salt ~98% (HPLC);N6-Methyladenosine 5'-monophosphate sodium salt >=97% (HPLC);ML-210N6-Methyladenosine 5'-monophosphate (sodium salt);N-Methyl-5'-adenylic acid disodium salt;6-Me-5'-AMP;N6-Methyladenosine 5'-monophosphate disodium salt
CAS No.81921-35-9

Synthetic Route by SureRoute

1. ACGFNG939 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGFNG939 route product structure diagram
    ACGFNG93981921-35-9
Inquiry

2. ACGFNG939 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBFSC511 route compound structure diagram
    ACBFSC51143086-58-4
  4. Then
  5. ACGFNG939 route product structure diagram
    ACGFNG93981921-35-9
Inquiry

Comments (0)